Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ Carbonic Anhydrase IV Polyclonal Antibody
Goat Polyclonal Antibody
Supplier: Invitrogen™ PA547266
Description
In direct ELISAs and Western blots, approximately 20% cross-reactivity with recombinant mouse CA4 is observed and less than 5% cross-reactivity with recombinant human CA1, 2, 3, 8, 9, 10, 12, and 13 is observed. Reconstitute at 0.2 mg/mL in sterile PBS.
Carbonic anhydrases are a large family of zinc metalloenzymes that catalyze the reversible hydration of carbon dioxide. They participate in a variety of biological processes, including respiration, calcification, acid-base balance, bone resorption, and the formation of aqueous humor, cerebrospinal fluid, saliva, and gastric acid. They show extensive diversity in tissue distribution and in their subcellular localization. This gene encodes a glycosylphosphatidyl-inositol-anchored membrane isozyme expressed on the luminal surfaces of pulmonary capillaries and proximal renal tubules. Its exact function is not known, however, it may have a role in inherited renal abnormalities of bicarbonate transport.
Specifications
Carbonic Anhydrase IV | |
Polyclonal | |
Unconjugated | |
CA4 | |
AW456718; CA IV; CA4; CAIV; CA-IV; Car4; Carbonate dehydratase IV; carbonic anhydrase 4; Carbonic anhydrase IV; carbonic dehydratase IV; RP17 | |
Goat | |
Antigen affinity chromatography | |
RUO | |
762 | |
-20°C, Avoid Freeze/Thaw Cycles | |
Lyophilized |
Immunohistochemistry, Immunoprecipitation, Western Blot | |
0.2 mg/mL | |
PBS with 5% trehalose and No Preservative | |
P22748 | |
CA4 | |
Mouse myeloma cell line NS0-derived recombinant human Carbonic AnhydraseIV/CA4 Ala19-Lys283. | |
100 μg | |
Primary | |
Human | |
Antibody | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction